G01N 2333/908
Acting on hydrogen peroxide as acceptor
Official title: acting on hydrogen peroxide as acceptor (1.11)
G01N2333/908 (Acting on hydrogen peroxide as acceptor) appears on 126 US grants and 254 published applications in this corpus.
Search patents in G01N- Granted patents
- 126
- Published applications
- 254
- Assignees
- 178
- Inventors
- 577
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 3 |
| 2003 | 1 | 4 |
| 2004 | 3 | 2 |
| 2005 | 4 | 8 |
| 2006 | 1 | 3 |
| 2007 | 2 | 3 |
| 2008 | 3 | 8 |
| 2009 | 3 | 6 |
| 2010 | 3 | 7 |
| 2011 | 2 | 3 |
| 2012 | 3 | 7 |
| 2013 | 3 | 13 |
| 2014 | 5 | 7 |
| 2015 | 7 | 7 |
| 2016 | 9 | 25 |
| 2017 | 9 | 17 |
| 2018 | 3 | 12 |
| 2019 | 15 | 14 |
| 2020 | 6 | 8 |
| 2021 | 13 | 15 |
| 2022 | 5 | 9 |
| 2023 | 6 | 10 |
| 2024 | 7 | 18 |
| 2025 | 5 | 23 |
| 2026 | 6 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for reducing measurement error8 Sep 2026US 12,730,116 B2Sekisui Medical Co., Ltd.
- Analyte sensors employing multiple enzymes and methods associated therewith7 Jul 2026US 12,672,803 B2Abbott Diabetes Care Inc.
- Analyte sensors employing multiple enzymes and methods associated therewith7 Jul 2026US 12,672,804 B2Abbott Diabetes Care Inc.
- Analyte sensors employing multiple enzymes and methods associated therewith7 Jul 2026US 12,672,805 B2Abbott Diabetes Care Inc.
- Analyte sensors employing multiple enzymes and methods associated therewith17 Mar 2026US 12,575,769 B2Abbott Diabetes Care Inc.
- Analyte sensors employing multiple enzymes and methods associated therewith1 Oct 2026US 2026/0294295 A1Abbott Diabetes Care Inc.
- Anti-CLDN18_2 Antibody and an In Vitro Diagnostic Kit1 Oct 2026US 2026/0298936 A1Jiangsu Aosaikang Biopharmaceutical Co., Ltd.
- Anti-sars-cov-2 spike (s) immunoassay and methods of use thereof3 Sep 2026US 2026/0259220 A1Novavax, Inc.
- Derivatives, immunogens, and antibodies and use of the same in detection of ecstasy-class compounds13 Aug 2026US 2026/0234121 A1Siemens Healthcare Diagnostics Inc.
- Point-of-Care Device for the Determination of Adenosine Deaminase Activity in Biological Samples13 Aug 2026US 2026/0234691 A1DADA2 Foundation
Most cited
By later US patents
- Sensor material, sensor and detection method for bio-substance159US 6,780,647 B2Fuji Xerox Co., Ltd. · 2004
- Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool100US 7,129,053 B1DakoCytomation Denmark A/S · 2006
- Fet sensor with specially configured gate electrode for the highly sensitive detection of analytes26US 7,632,670 B2Forschungszentrum Julich GmbH · 2009
- Myeloperoxidase, a risk indicator for cardiovascular disease19US 7,223,552 B2The Cleveland Clinic Foundation · 2007
- Stabilized lactate responsive enzymes, electrodes and sensors, and methods for making and using the same18US 9,914,952 B2Abbott Diabetes Care Inc. · 2018